Skip to main content
. 2018 Oct 4;2018(10):CD005179. doi: 10.1002/14651858.CD005179.pub4

Tak 2006.

Study characteristics
Methods RCT. 6 arms.
Participants Number of children: 20 control, 20 treatment
Sex of children: 25 M, 15 F
Age range of children: 3 ‐ 12 years
Mean age of children: 6.6 ± 2.9 years (intervention); 6.6 ± 2.7 years (control)
Needle procedure: venepuncture
Diagnosis: none reported
Inclusion criteria: Dutch children receiving a venepuncture
Exclusion criteria: children of non‐Dutch parentage
Setting: outpatient centre of the St Antonius Ziekenhuis in Nieuwegein (the Netherlands)
Interventions Definitions for the following condition components are provided below.
1. Placebo, distraction, information
2. EMLA, distraction, information
3. Placebo, information
4. EMLA, information
5. Information
6. Non‐treatment control
Distraction: During the venepuncture, a funny 6‐minute fragment of a video cartoon (Walk Disney's 'Beauty and the Beast') was shown. Sound could be heard through a headphone.
Procedural Information: All children except those in the control groups received information on the venepuncture by means of a photo book. The supervising research assistant asked the child to read the book with his/her parent(s) while in the waiting room. The 24 photos, each accompanied by a short and simple text, showed step‐by‐step what was to come from entrance to departure from the hospital. A boy 8 years old acted as the model.
EMLA: EMLA cream was applied by the laboratory personnel on duty who did not know whether the cream was EMLA or a placebo cream. These were not necessarily the same persons as those who did the pricking.
Placebo: A placebo cream was applied by the laboratory personnel on duty who did not know whether the cream was EMLA or a placebo cream. These were not necessarily the same persons as those who did the pricking.
*Because EMLA requires 1 hour to produce its effect, the children in the4 ‘cream conditions’ passed that time in the waiting room in the presence of their parent(s).
Non‐treatment control: no treatment provided
Outcomes Pain measure:
  • Child self‐report: Oucher scale (for children < 6 years)

  • Child self‐report: VAS (for children > 6 years)


Distress measure:
  • Behavioral: Groningen Distress Scale (GDS)


Adverse events: none mentioned
Notes We used a total N of 94 for this study (instead of 136) because we only included 4 of 6 conditions (i.e. placebo, distraction, information versus placebo, information and information versus non‐treatment control). Although GDS ratings were calculated at 3 time points in this study (child entering the room, just before venepuncture, and during venepuncture), we only used the 'during venepuncture' scores in the analyses for this review.
Study dates: September 1993 to February 1995
Funding: none stated
Conflicts of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Randomized ‐ no further details. Insufficient information to permit judgment of 'low' or 'high' risk
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment of 'low' or 'high' risk
Blinding of participants and personnel (performance bias)
All outcomes High risk Participants and personnel were not blinded
Blinding of outcome assessment (detection bias)
All outcomes High risk No blinding of outcome assessment
Incomplete outcome data (attrition bias)
All outcomes Unclear risk No reasons for missing data provided
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judgment of 'low' or 'high' risk
Other bias Unclear risk Insufficient information to assess whether an important risk of bias exists